======= SHMT1 ======= == Gene Information == * **Official Symbol**: SHMT1 * **Official Name**: serine hydroxymethyltransferase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6470|6470]] * **UniProt**: [[https://www.uniprot.org/uniprot/P34896|P34896]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SHMT1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SHMT1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/182144|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the cytosolic form of serine hydroxymethyltransferase, a pyridoxal phosphate-containing enzyme that catalyzes the reversible conversion of serine and tetrahydrofolate to glycine and 5,10-methylene tetrahydrofolate. This reaction provides one-carbon units for synthesis of methionine, thymidylate, and purines in the cytoplasm. This gene is located within the Smith-Magenis syndrome region on chromosome 17. A pseudogene of this gene is located on the short arm of chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]. * **UniProt Summary**: Interconversion of serine and glycine (PubMed:8505317, PubMed:24698160). {ECO:0000269|PubMed:24698160, ECO:0000269|PubMed:8505317}. |SHMT| |L-allo-threonine aldolase activity| |glycine biosynthetic process from serine| |response to tetrahydrofolate| |glycine hydroxymethyltransferase activity| |cellular response to tetrahydrofolate| |cobalt ion binding| |serine binding| |dTMP metabolic process| |glycine biosynthetic process| |dTMP biosynthetic process| |L-serine catabolic process| |carnitine biosynthetic process| |pyrimidine deoxyribonucleoside monophosphate biosynthetic process| |pyrimidine deoxyribonucleoside monophosphate metabolic process| |amino-acid betaine biosynthetic process| |pyrimidine deoxyribonucleotide biosynthetic process| |deoxyribonucleoside monophosphate biosynthetic process| |tetrahydrofolate interconversion| |purine nucleobase biosynthetic process| |deoxyribose phosphate biosynthetic process| |L-serine metabolic process| |2-deoxyribonucleotide biosynthetic process| |deoxyribonucleoside monophosphate metabolic process| |carnitine metabolic process| |serine family amino acid catabolic process| |deoxyribonucleotide biosynthetic process| |translation repressor activity, mRNA regulatory element binding| |pyrimidine nucleoside monophosphate biosynthetic process| |pyrimidine nucleoside monophosphate metabolic process| |serine family amino acid biosynthetic process| |amino acid binding| |amino-acid betaine metabolic process| |glycine metabolic process| |tetrahydrofolate metabolic process| |nucleobase biosynthetic process| |folic acid metabolic process| |pyrimidine deoxyribonucleotide metabolic process| |purine nucleobase metabolic process| |mRNA 5-UTR binding| |one-carbon metabolic process| |folic acid-containing compound metabolic process| |2-deoxyribonucleotide metabolic process| |deoxyribose phosphate metabolic process| |pteridine-containing compound metabolic process| |deoxyribonucleotide metabolic process| |serine family amino acid metabolic process| |nucleobase metabolic process| |neurotransmitter biosynthetic process| |nucleoside monophosphate biosynthetic process| |cellular modified amino acid biosynthetic process| |pyrimidine nucleotide biosynthetic process| |pigment biosynthetic process| |pyridoxal phosphate binding| |pyrimidine-containing compound biosynthetic process| |pyrimidine nucleotide metabolic process| |pigment metabolic process| |alpha-amino acid biosynthetic process| |nucleoside monophosphate metabolic process| |cellular amino acid biosynthetic process| |water-soluble vitamin metabolic process| |neurotransmitter metabolic process| |protein homotetramerization| |cellular response to leukemia inhibitory factor| |response to leukemia inhibitory factor| |dicarboxylic acid metabolic process| |pyrimidine-containing compound metabolic process| |alpha-amino acid catabolic process| |vitamin metabolic process| |cellular amino acid catabolic process| |negative regulation of translation| |negative regulation of cellular amide metabolic process| |protein tetramerization| |purine-containing compound biosynthetic process| |ammonium ion metabolic process| |cellular modified amino acid metabolic process| |cellular response to acid chemical| |alpha-amino acid metabolic process| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |coenzyme metabolic process| |carboxylic acid catabolic process| |organic acid catabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |cellular amino acid metabolic process| |protein homooligomerization| |response to acid chemical| |regulation of translation| |regulation of neurotransmitter levels| |purine-containing compound metabolic process| |regulation of cellular amide metabolic process| |small molecule catabolic process| |cofactor metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |drug metabolic process| |protein complex oligomerization| |posttranscriptional regulation of gene expression| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |cellular response to organic cyclic compound| |small molecule biosynthetic process| |cellular response to organonitrogen compound| |carbohydrate derivative biosynthetic process| |cellular response to nitrogen compound| |cellular amide metabolic process| |zinc ion binding| |protein homodimerization activity| |organophosphate metabolic process| |carboxylic acid metabolic process| |response to organic cyclic compound| |response to organonitrogen compound| |oxoacid metabolic process| |cellular response to cytokine stimulus| |organic acid metabolic process| |carbohydrate derivative metabolic process| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |organonitrogen compound catabolic process| |identical protein binding| |response to nitrogen compound| |nucleobase-containing compound biosynthetic process| |response to cytokine| |negative regulation of protein metabolic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |cellular response to endogenous stimulus| |organic cyclic compound biosynthetic process| |negative regulation of cellular macromolecule biosynthetic process| |organonitrogen compound biosynthetic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |protein-containing complex assembly| |cellular nitrogen compound biosynthetic process| |negative regulation of gene expression| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-1.89| |[[:results:exp220|BAY-598 4μM R05 exp220]]|-1.82| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|1.75| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9245 * **Expression level (log2 read counts)**: 5.77 {{:chemogenomics:nalm6 dist.png?nolink |}}